Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells
Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells
复制标题
DOI:
10.1128/jvi.00974-13
复制
发表时间:
2013-07-01
影响因子:
5.4
通讯作者:
Shimotohno, Kunitada
中科院分区:
文献类型:
--
作者:
Nishitsuji, Hironori;Funami, Kenji;Shimotohno, Kunitada
Inflammatory cytokines and chemokines play important roles in inflammation during viral infection. Hepatitis C virus (HCV) is a hepatotropic RNA virus that is closely associated with chronic liver inflammation, fibrosis, and hepatocellular carcinoma. During the progression of HCV-related diseases, hepatic stellate cells (HSCs) contribute to the inflammatory response triggered by HCV infection. However, the underlying molecular mechanisms that mediate HSC-induced chronic inflammation during HCV infection are not fully understood. By coculturing HSCs with HCV-infected hepatocytes in vitro, we found that HSCs stimulated HCV-infected hepatocytes, leading to the expression of proinflammatory cytokines and chemokines such as interleukin-6 (IL-6), IL-8, macrophage inflammatory protein 1 alpha (MIP-1 alpha), and MIP-1 beta. Moreover, we found that this effect was mediated by IL-1 alpha, which was secreted by HSCs. HCV infection enhanced production of CCAAT/enhancer binding protein (C/EBP) beta mRNA, and HSC-dependent IL-1 alpha production contributed to the stimulation of C/EBP beta target cytokines and chemokines in HCV-infected hepatocytes. Consistent with this result, knockdown of mRNA for C/EBP beta in HCV-infected hepatocytes resulted in decreased production of cytokines and chemokines after the addition of HSC conditioned medium. Induction of cytokines and chemokines in hepatocytes by the HSC conditioned medium required a yet to be identified postentry event during productive HCV infection. The cross talk between HSCs and HCV-infected hepatocytes is a key feature of inflammation-mediated, HCV-related diseases.